PGDx elio plasma resolve is a pan solid tumor NGS liquid biopsy assay that identifies key genomic alterations and guideline-supported biomarkers with high accuracy and sensitivity. It features proprietary methods for detecting microsatellite instability (MSI), as well as complex structural alterations and amplifications.